| [1] |
Kamangar F,Dores GM,Anderson WF.Pattern of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world.J Clin Oncol,2006,24:2137-2150.
|
| [2] |
Tamaki K,Moriya T,Sato Y,et al.Vasohibin-1 in human breast carcinoma:A potential negative feedback regulator of angiogenesis.Cancer Sci,2009,100:88-94.
|
| [3] |
Fox SB,Generali DG,Harris AL.Breast tumour angiogenesis.Breast Cancer Res,2007,9:216.
|
| [4] |
Deng G,Lu Y,Zlotnikov G,Thor A,et al.Loss of heterozygosty in normal tissue adjacent to breast carcinomas.Sience,1996,274:2057-2059.
|
| [5] |
Folkman J.Tumor angiogenesis:therapeutic implications.N Engl J Med,1971,285:1182-1186.
|
| [6] |
Banerjee S,Dowsett M,Ashworth A,et al.Mechanisms of disease:angiogenesis and the management of breast cancer.Natl Clin Pract Oncol,2007,4:536-550.
|
| [7] |
Sato Y,Sonoda H.The vasohibin family:a negative feedback regulatory system of angiogenesis generally programmed in endothelial cells.Arterioscl Thromb Vasc Biol,2007,27:37-41.
|
| [8] |
Sato Y.Update on endogenous inhibitors of angiogenesis.Endothelium,2006,13:147-155.
|
| [9] |
Rosen PP.Rosen's Breast Pathology.3rd ed.Philadelphia:Lippincott Williams& Wilkins,2009.
|
| [10] |
Horak ER,Leek R,Klenk N,et al.Angiogenesis,assessed by platelet/endothelial cell adhesion molecule antibodies,as indicator of node metastases and survival in breast cancer.Lancet,1992,340:1120-1124.
|
| [11] |
Uzzan B,Nicolas P,Cucherat M,et al.Microvessel density as a prognostic factor in women with breast cancer:a systematic review of the literature and meta-analysis.Cancer Res,2004,64:2941-2955.
|
| [12] |
Siitonen SM,Haapasalo HK,Rantala IS,et al.Comparison of different immunohistochemical methods in the assessment of angiogenesis:lack of prognostic value in a group of 77 selected node-negative breast carcinomas.Mod Pathol,1995,8:745-752.
|
| [13] |
Weidner N,Semple JP,Welch WR,et al.Tumor angiogenesis and metastasis correlation in in invasive breast carcinoma.N Engl J Med,1991,324:1-8.
|
| [14] |
Weidner N.Measuring intratumoral microvessel density.Methods Enzymol,2008,444:305-323.
|
| [15] |
Chalkley HW.Method for the quantitative morphologic analysis of tissues.J Natl Cancer Inst,1943,4:47-53.
|
| [16] |
Fox SB,Leek RD,Weekes MP,et al.Quantitation and prognostic value of breast cancer angiogenesis:comparison of microvessel density,Chalkley count,and computer image analysis.J Pathol,1995,177:275-284.
|
| [17] |
Hansen S,Sorensen FB,Vach W,et al.Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.Histopathology,2004,44:428-436.
|
| [18] |
Barbareschi M,Gasparini G,Morelli L,et al.Novel methods for the determination of the angiogenic activity of human tumors.Breast Cancer Res Treat,1995,36:181-192.
|
| [19] |
Watanabe K,Hasegawa Y,Yamashita H,et al.Vasohibin as an endothelium derived negative feedback regulator of angiogenesis.J Clin Invest,2004,114:898-907.
|
| [20] |
Tamaki K,Sasano H,Maruo Y,et al.Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast.Cancer Sci,2010,101:1051-1058.
|
| [21] |
Folkman J.Tumor angiogenesis:therapeutic implications.N Engl J Med,1971,285:1182-1186.
|
| [22] |
Ferrara N,Houck K,Jakeman L,et al.Molecular and biological properties of the vascular endothelial growth factor family of proteins.Endocr Rev,1992,13:18-32.
|
| [23] |
Linderholm B,Grankvist K,Wilking N,et al.Correlation of vascular endothelial growth factor content with recurrences,survival,and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.J Clin Oncol,2000,18:1423-1431.
|
| [24] |
Gasparini G,Toi M,Gion M,et al.Prognostic significance of vascular endothelial growth factor protein in nodenegative breast carcinoma.J Natl Cancer Inst,1997,89:139-147.
|
| [25] |
Wedam SB,Low JA,Yang SX,et al.Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.J Clin Oncol,2006,24:769-777.
|
| [26] |
Kim KJ,Li B,Winer J,et al.Inhibitor of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.Nature,1993,362:841-844.
|
| [27] |
Goldhirsch A,Ingle JN,Gelber RD,et al.Thresholds for therapies:highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009.Ann Oncol,2009,20:1319-1329.
|
| [28] |
Sinclair S,Zimmer AS,Swain SM.HER-2 targeting agents and antiangiogenic therapy:evaluation of adjuvant therapy in breast cancer.ASCO 2009 Educational book.http://www.asco.org/ascov2/Education+&+Training/Educational+Book? &vmview=edbk_detail_view&confID=65&abstractID=1
|